Cited by 61Gut microbiota and healthFatty Acid Research and HealthAdipokines, Inflammation, and Metabolic Diseases

Omega-3 fatty acids prevent early-life antibiotic exposure-induced gut microbiota dysbiosis and later-life obesity

Kaliannan, K, Wang, B, Li, X-Y, Bhan, A K, Kang, J X·2016·International Journal of Obesity

Abstract

Early-life antibiotic exposure can disrupt the founding intestinal microbial community and lead to obesity later in life. Recent studies show that omega-3 fatty acids can reduce body weight gain and chronic inflammation through modulation of the gut microbiota. We hypothesize that increased tissue levels of omega-3 fatty acids may prevent antibiotic-induced alteration of gut microbiota and obesity later in life. Here, we utilize the fat-1 transgenic mouse model, which can endogenously produce omega-3 fatty acids and thereby eliminates confounding factors of diet, to show that elevated tissue levels of omega-3 fatty acids significantly reduce body weight gain and the severity of insulin resistance, fatty liver and dyslipidemia resulting from early-life exposure to azithromycin. These effects were associated with a reversal of antibiotic-induced dysbiosis of gut microbiota in fat-1 mice. These results demonstrate the beneficial effects of omega-3 fatty acids on antibiotic-induced gut dysbiosis and obesity, and suggest the potential utility of omega-3 supplementation as a safe and effective means for the prevention of obesity in children who are exposed to antibiotics.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ijo.2016.27

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Early-life exposure to omega-3 prevented the onset of metabolic disorders known to be mediated through a perturbed gut microbiota profile post-antibiotic treatment.

    “early-life exposure to omega-3 prevented the onset of metabolic disorders known to be mediated through a perturbed gut microbiota profile post-antibiotic treatment (Kaliannan et al., 2016).”

    From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Kaliannan et al., 2016

    The Results and Discussion (pp. 2–3) report that fat-1 mice with elevated omega-3 levels were largely protected against metabolic changes after early-life azithromycin exposure, and the paper reports associated changes in gut microbiota. But the paper describes reduced severity of some metabolic outcomes rather than complete prevention, and treats microbiota changes as an associated or proposed mechanism rather than demonstrating that they mediated the protection. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kaliannan, K., Wang, B., Li, X.-Y., Bhan, A. K., & Kang, J. X.
Affiliations
Harvard University (US)
Corresponding author
Kang, J X
Venue
International Journal of Obesity
Published
2016-02-15
Volume
40
Issue
6
Pages
1039-1042
ISSN
  • 0307-0565 (ISSN-L)
  • 1476-5497
OpenAlex
W2287487780
Cited by
61
References
16
Citations by year
2026: 2 · 2025: 2 · 2024: 3 · 2023: 5 · 2022: 4 · 2021: 8 · 2020: 6 · 2019: 8 · 2018: 11 · 2017: 9 · 2016: 3
FWCI
5.37
Type
journal article
Language
en
Open access
closed
Locations
  • International Journal of Obesity (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
Keywords
omega-3 fatty acids, early-life antibiotic exposure, gut dysbiosis, obesity, fat-1 transgenic mice, azithromycin, insulin resistance, hepatic steatosis, dyslipidemia, chronic inflammation, omega-3 supplementation, childhood obesity prevention
MeSH terms
Gastrointestinal Microbiome, Animals, Anti-Bacterial Agents, Disease Models, Animal, Inflammation, Male, Obesity, Weight Gain, Fatty Acids, Omega-3, Mice, Dysbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review